Approvals/TGA/CIPLA TENOFOVIR + EMTRICITABINE 300/200 Tenofovir disoproxil fumarate 300 mg and emtricitabine 200 mg tablet bottle pack

Approved

STANDARD

CIPLA TENOFOVIR + EMTRICITABINE 300/200 Tenofovir disoproxil fumarate 300 mg and emtricitabine 200 mg tablet bottle pack

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f3ffb52b3cdc3aea
Product Name: CIPLA TENOFOVIR + EMTRICITABINE 300/200 Tenofovir disoproxil fumarate 300 mg and emtricitabine 200 mg tablet bottle pack
Artg Id: 327898
Artg Name: CIPLA TENOFOVIR + EMTRICITABINE 300/200 Tenofovir disoproxil fumarate 300 mg and emtricitabine 200 mg tablet bottle pack
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2020-12-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/9dc2a7215c2708d37f3c64dee5052022.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/0f14a09acbe635ad7d12777e0e84f40a.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

f3ffb52b3cdc3aea

Type

Standard